Organogenesis Holdings (ORGO) Times Interest Earned (2017 - 2026)
Organogenesis Holdings (ORGO) recorded quarterly Times Interest Earned of $181.29 in Q1 2026, up 250.34% quarter-over-quarter from -$120.59 in Q4 2025, and up 551.39% on a YoY basis from $27.83 in Q1 2025.
Organogenesis Holdings (ORGO) Times Interest Earned (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Times Interest Earned history runs 10 years deep, the most recent figure standing at $181.29 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 551.39% year-over-year to $181.29; the TTM figure through Mar 2026 stood at $18.99 (up 105.42% YoY), while the FY2025 annual figure was -$4.32, down 420.41% from the prior year.
- Times Interest Earned was $181.29 for Q1 2026 at Organogenesis Holdings, up from -$120.59 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $181.29 in Q1 2026 to a low of -$290.6 in Q4 2022.
- Historically, Times Interest Earned has averaged -$21.9 across 5 years, with a median of -$0.17 in 2022.
- The sharpest annual moves came in 2024 and 2026: Times Interest Earned plunged 6527.06% in 2024, then surged 551.39% in 2026.
- A 5-year view of Times Interest Earned shows it stood at -$290.6 in 2022, then surged by 99.13% to -$2.53 in 2023, then slumped by 6527.06% to -$167.52 in 2024, then increased by 28.02% to -$120.59 in 2025, then soared by 250.34% to $181.29 in 2026.
- The last three Times Interest Earned figures came in at $181.29 (Q1 2026), -$120.59 (Q4 2025), and -$49.94 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.31 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.72 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Organogenesis Holdings | 304.80 Mn | 212.70 Mn | 11.46 Mn | 181.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 181.29 |
| Dec 31, 2025 | -120.59 |
| Sep 30, 2025 | -49.94 |
| Jun 30, 2025 | 18.80 |
| Mar 31, 2025 | 27.83 |
| Dec 31, 2024 | -167.52 |
| Sep 30, 2024 | 13.25 |
| Jun 30, 2024 | -22.41 |
| Mar 31, 2024 | -7.49 |
| Dec 31, 2023 | -2.53 |
| Sep 30, 2023 | 18.13 |
| Jun 30, 2023 | 16.41 |
| Mar 31, 2023 | -6.16 |
| Dec 31, 2022 | -290.60 |
| Sep 30, 2022 | 3.11 |
| Jun 30, 2022 | 16.35 |
| Mar 31, 2022 | -0.17 |
| Dec 31, 2021 | 23.15 |
| Sep 30, 2021 | 10.97 |
| Jun 30, 2021 | 9.70 |